American association of clinical endocrinologists and American college of endocrinology - Clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015 -

Endocrine Practice

Volumn 21, Issue 4, 2015, Pages 413-437

  Handelsman, Yehuda ^a   Bloomgarden, Zachary T ^b   Grunberger, George ^c   Umpierrez, Guillermo ^d   Zimmerman, Robert S ^e   Bailey, Timothy S ^f   Blonde, Lawrence ^g   Bray, George A ^h   Jay Cohen, A ⁱ   Dagogo Jack, Samuel ^j   Davidson, Jaime A ^k   Einhorn, Daniel ^l   Ganda, Om P ^m   Garber, Alan J ⁿ   Timothy Garvey, W ^o   Henry, Robert R ^p   Hirsch, Irl B ^q   Horton, Edward S ^m   Hurley, Daniel L ^r   Jellinger, Paul S ^s,t   Jovanovic, Lois ^u   Lebovitz, Harold E ^v   LeRoith, Derek ^b   Levy, Philip ^w   McGill, Janet B ^x   Mechanick, Jeffrey I ^b   Mestman, Jorge H ^u   Moghissi, Etie S ^y   Orzeck, Eric A ^z   Pessah Pollack, Rachel ^b,aa   Rosenblit, Paul D ^ab,ac,ad   Vinik, Aaron I ^ae   Wyne, Kathleen ^af   Zangeneh, Farhad ^ag   more..

^a Metabolic Institute of America American College of Endocrinology   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g OCHSNER MEDICAL CENTER   (United States)

^h LOUISIANA STATE UNIVERSITY   (United States)

ⁱ Endocrine Clinic   (United States)

^j UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^k UNIVERSITY OF TEXAS AT DALLAS   (United States)

^l Whittier Institute for Diabetes   (United States)

^m HARVARD MEDICAL SCHOOL   (United States)

ⁿ BAYLOR COLLEGE OF MEDICINE   (United States)

^o UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^r MAYO CLINIC   (United States)

^s UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^t Center for Diabetes and Endocrine Care   (United States)

^u UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^v SUNY DOWNSTATE MEDICAL CENTER   (United States)

^w UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^x WASHINGTON UNIVERSITY   (United States)

^y UNIVERSITY OF CALIFORNIA   (United States)

^z Endocrinology Associates   (United States)

^aa ProHEALTH Care Associates LLP   (United States)

^ab UNIVERSITY OF CALIFORNIA   (United States)

^ac UNIVERSITY OF CALIFORNIA   (United States)

^ad Diabetes/Lipid Management and Research Center   (United States)

^ae EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^af HOUSTON METHODIST HOSPITAL   (United States)

^ag Vet Aff Med Ctr Dept Med T   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ACETYLSALICYLIC ACID; APOLIPOPROTEIN B; CARBOHYDRATE; CREATININE; FAT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOPHANE INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; TRACE ELEMENT; TRIACYLGLYCEROL;

BODY WEIGHT LOSS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DYSLIPIDEMIA; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MEDICAL DECISION MAKING; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PREGNANCY DIABETES MELLITUS; QUALITY OF LIFE; REVIEW; RISK FACTOR; HEALTH CARE;

COMPREHENSIVE HEALTH CARE; DIABETES MELLITUS; HUMANS;

EID: 84930841315     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP15672.GL     Document Type: Review

References (36)

1. Handelsman Y, Mechanick JI, Blonde L, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011;17 Suppl 2:1-53. [EL 4; NE]
2. Mechanick JI, Camacho PM, Cobin RH, et al. American Association of Clinical Endocrinologists Protocol for Standardized Production of Clinical Practice Guidelines--2010 update. Endocr Pract. 2010;16:270-83. [EL 4; CPG NE; see Fig. 1; Tables 1-4]
3. Mechanick JI, Camacho PM, Garber AJ, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Protocol for Standardized Production of Clinical Practice Guidelines, Algorithms, and Checklists - 2014 Update and the AACe G4G Program. Endocr Pract. 2014;20:692-702. [EL 4; CPG NE; see Tables 1-4]
4. Garber AJ, Abrahamson MJ, Barzilay JI, et al. American association of clinical endocrinologists/ American college of endocrinology' comprehensive dia¬ betes management algorithm 2015. Endocr Pract. 2015; 21:438-447. [EL 4; NE]
5. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15:353-369. [EL 4; consensus NE]
6. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pres¬ sure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-520. [EL 4; NE]
7. Younis N, Williams S, Ammori B, Soran H. Role of aspirin in the primary prevention of cardiovascular dis¬ ease in diabetes mellitus: a meta-analysis. Expert Opin Pharmacother. 2010;11:1459-1466. [EL 1; MRCT but small sample sizes and event rates]
8. Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L, et al. Aspirin in the primary and second¬ ary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849-1860. [EL 1; MRCT]
9. Zhang C, Sun A, Zhang P, et al. Aspirin for primary pre¬ vention of cardiovascular events in patients with diabetes: A meta-analysis. Diabetes Res Clin Pract. 2010;87:211-218. [EL 1; MRCT]
10. Ong g, Davis TM, Davis WA. Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: the Fremantle Diabetes study. Diabetes Care. 2010;33:317-321. [EL 2; PCS]
11. Lewis J E, Arheart K L, LeBlanc WG, et al. Food label use and awareness of nutritional information and recom¬ mendations among persons with chronic disease. Am J Clin Nutr. 2009;90:1351-1357. [EL 3; SS]
12. Craig WJ, Mangels AR; American Dietetic Association. Position of the American Dietetic Association: vegetarian diets. J Am Diet Assoc. 2009;109:1266-1282. [EL 4; posi¬ tion NE]
13. Dietary Guidelines for Americans, 2010. Washington, DC: US Government Printing Office; 2010. Available at: http://www.health.gov/dietaryguidelines/2010.asp [EL 4; posi¬ tion NE]
14. Jones JM, Anderson JW. Grain foods and health: a primer for clinicians. Phys Sportsmed. 2008;36:18-33. [EL 4; review NE]
15. Pawlak R, Colby S. Benefits, barriers, self-efficacy and knowledge regarding healthy foods; perception of African Americans living in eastern North Carolina. Nutr Res Pract. 2009;3:56-63. [EL 3; SS]
16. Birlouez-Aragon I, Saavedra G, Tessier FJ, et al. A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. Am J Clin Nutr. 2010;91:1220-1226. [EL 1; RCT]
17. Corsino L, Svetkey LP, Ayotte BJ, Bosworth HB. Patient characteristics associated with receipt of lifestyle behavior advice. N C Med J. 2009;70:391-398. [EL 3; SS]
18. Vuksan V, Rogovik AL, Jovanovski E, Jenkins AL. Fiber facts: benefits and recommendations for individuals with type 2 diabetes. Curr Diab Rep. 2009;9:405-411. [EL 4; review NE]
19. Wheeler ML, Pi-Sunyer FX. Carbohydrate issues: type and amount. J Am Diet Assoc. 2008;108:S34-S39. [EL 4; review NE]
20. Trinidad TP, Mallillin AC, Loyola AS, Sagum RS, Encabo RR. The potential health benefits of legumes as a good source of dietary fibre. Br J Nutr. 2010;103:569-574. [EL 4; review NE]
21. Hare-Bruun H, Nielsen BM, Grau K, Oxlund AL, Heitmann BL. Should glycemic index and glycemic load be considered in dietary recommendations? Nutr Rev. 2008;66:569-590. [EL 4; NE review]
22. Palou A, Bonet ML, Pico C . On the role and fate of sug¬ ars in human nutrition and health. Introduction. Obes Rev. 2009;10 Suppl 1:1-8. [EL 4; review NE]
23. Willcox DC, Willcox BJ, Todoriki H, Suzuki M. The Okinawan diet: health implications of a low-calorie, nutri¬ ent-dense, antioxidant-rich dietary pattern low in glycemic load. J Am Coll Nutr. 2009;28 Suppl:500S-516S. [EL 4; review NE]
24. Minihane AM, Harland JI. Impact of oil used by the fry¬ ing industry on population fat intake. Crit Rev Food Sci Nutr. 2007;47:287-297. [EL 4; review NE]
25. Micha R, Mozaffarian D. Saturated fat and cardiometa-bolic risk factors, coronary heart disease, stroke, and dia¬ betes: a fresh look at the evidence. Lipids. 2010;45:893-905. [EL 4; review NE]
26. Booker CS, Mann JI. Trans fatty acids and cardiovas¬ cular health: translation of the evidence base. Nutr Metab Cardiovasc Dis. 2008;18:448-456. [EL 4; NE review]
27. Micha R, Wallace SK, Mozaffarian D. Red and pro¬ cessed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation. 2010;121:2271-2283. [EL 2; MNRCT]
28. Vang A, Singh PN, Lee JW, Haddad E H, Brinegar C H . Meats, processed meats, obesity, weight gain and occur¬ rence of diabetes among adults: findings from Adventist Health Studies [Erratum in Ann Nutr Metab. 2010;56:232]. Ann Nutr Metab. 2008;52:96-104. [EL 2; PCS, data may not be generalizable to patients with diabetes already]
29. Mechanick JI, Brett EM, Chausmer AB, Dickey RA, Wallach S; American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for the clinical use of dietary supplements and nutraceuticals [Erratum in Endocr Pract. 2008;14:802-803]. Endocr Pract. 2003;9:417-470. [EL 4; CPG NE]
30. Kidney Disease: Improving Global Outcomes C K D Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1-150. [EL 4; NE]
31. Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80:17-28. [EL 4; NE]
32. Boulton AJ, Armstrong DG, Albert SF, et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care. 2008;31:1679-1685. [EL 4; NE]
33. Hanas R, Donaghue KC, Klingensmith G, Swift PG. ISPAD clinical practice consensus guidelines 2009 com¬ pendium. Introduction. Pediatr Diabetes. 2009;10 Suppl 12:1-2. [EL 4; CPG NE]
34. National Diabetes Education Program. Transitions From Pediatric to Adult Health Care. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases. Available at: http://ndep.nih.gov/transitions/. [EL 4; NE]
35. Peters A, Laffel L; American Diabetes Association Transitions Working group. Diabetes care for emerg¬ ing adults: recommendations for transition from pediatric to adult diabetes care systems: a position statement of the American Diabetes Association, with representation by the American College of Osteopathic Family Physicians, the American Academy of Pediatrics, the American Association of Clinical Endocrinologists, the American Osteopathic Association, the Centers for Disease Control and Prevention, Children with Diabetes, The Endocrine Society, the International Society for Pediatric and Adolescent Diabetes, Juvenile Diabetes Research Foundation International, the National Diabetes Education Program, and the Pediatric Endocrine Society (formerly Lawson Wilkins Pediatric Endocrine Society). Diabetes Care. 2011;34:2477-85. [EL 4; NE]
36. Juvenile Diabetes Research Foundation. Life Stages. New York, NY: JDRF. Available at: http://jdrf.org/lifewith-t1d/#life-stages. [EL 4; NE]